Divacs

Developing cell-based immunotherapies for Type 1 Diabetes and SARS-CoV2

placeSan Diego, California, United States calendar_todayFounded 2013 language diavacs.com

Registered entities

Investor mix

1 investor on record.

Investor typeCountShare
Other / undisclosed1100%
Coming soon